A stabilised vitamin powder comprises one or both of gliadin an glutenin and a vitamin(s). It is preferable that the powder comprises 100 parts by weight of gliadin and/or glutenin and 1 to 51 parts by weight of vitamins. In the invention, the vitamins may be clathrated and/or coated with gliadin and/or glutenin.
